Company Filing History:
3 out of 52 
1 out of 1 
1 out of 1 Years Active: 2002-2011
Title: The Innovations of Stephen Lye
Introduction
Stephen Lye is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of medical diagnostics, particularly in relation to preeclampsia. With a total of five patents to his name, Lye's work has the potential to impact the health and well-being of many patients.
Latest Patents
Lye's latest patents include a method for diagnosing an increased risk of preeclampsia by measuring the level of HIF-1α. This innovative method provides a way to diagnose and treat patients who are at an increased risk of developing this condition. The methods involve measuring levels of TGF-β, receptors of cytokines of the TGF-β family, or HIF-1α. Another patent focuses on early diagnosing of an increased risk of preeclampsia, utilizing similar measurement techniques.
Career Highlights
Throughout his career, Stephen Lye has worked with esteemed organizations, including Mount Sinai Hospital Corporation. His work in these institutions has allowed him to collaborate with leading professionals in the medical field, further enhancing his contributions to medical science.
Collaborations
Lye has collaborated with notable colleagues such as Isabella Caniggia and Martin Post. These partnerships have likely enriched his research and development efforts, leading to innovative solutions in the medical diagnostics arena.
Conclusion
Stephen Lye's contributions to the field of medical diagnostics, particularly regarding preeclampsia, showcase his innovative spirit and dedication to improving patient care. His patents reflect a commitment to advancing medical science and enhancing the lives of patients at risk.